Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade
Axsome Therapeutics, Inc.'s' stock surges 30% amid key catalysts. Learn why it's now rated a Buy wih upcoming data opportunities. Click for my AXSM update.
Fortum Oyj (FOJCF) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call February 11, 2025 4:00 AM ETCompany ParticipantsIngela Ulfves - Head of Investor ...
Impacts11h
AI-Powered PowerPoint Presentations: Revolutionizing the Way We Create and Deliver Presentations
In today’s fast-paced digital world, creating engaging and professional presentations has become more crucial than ever. The ...
Earnings call transcript: Atomera Q4 2024 reports revenue miss, stock drops
Atomera Inc (ATOM) reported its fourth-quarter 2024 earnings, showcasing a significant revenue shortfall compared to expectations, leading to a sharp decline in its stock price during after-hours ...
Earnings call transcript: Hanza AB reports Q4 2024 results, stock dips
Hanza AB's earnings call for the fourth quarter of 2024 revealed a mixed financial performance, leading to an 8.44% drop in its stock price. The company reported strong sales growth due to ...